LEGAL ACTION UPDATE:
On April 1, 2020, the FDA requested an immediate recall of all ranitidine (Zantac) products from the market. Zantac is linked to an increased risk of cancer.
Ranitidine, known under the brand name of Zantac, is a heartburn medication that, for years, was sold both over the counter and as a prescription. GSK developed Zantac in 1977 and was approved by the FDA in 1983. In 2004, Pfizer developed an over-the-counter version, then sold it to Boehringer Ingelheim in 2006. Later, Sanofi-AS purchased OTC Zantac in 2017. To date, there are more than 20 different generic manufacturers of ranitidine. However, recent studies have shown Zantac may contain unsafe amounts of the carcinogen NDMA, a known probable carcinogen.
If you or your loved one was diagnosed with cancer after taking Zantac, we may be able to help. Call 888-783-8378 for your free case evaluation.
What is NDMA?
NDMA stands for Ni-nitrosodimethylamine. NDMA is classified as a probable human carcinogen, which is a substance that causes cancer. It is not only usd to manufacture rocket fuel, but it is also used to induce tumors in animals for laboratory experiments. The FDA’s daily allowable limit is 96ng.
On September 13, 2019, FDA issued a statement that some ranitidine products contain NDMA at low levels. On October 2, 2019, the FDA disclosed that they found “unacceptable levels of NDMA in samples of ranitidine. This statement prompted voluntary recalls across the world. Additionally, Canada asked companies to stop distributing Zantac and France recalled all ranitidine products.
What is the problem with Zantac antacid?
Valisure LLC and ValisureRX LLC conducted tests, finding very high levels of NDMA in all lots of ranitidine tested. Valisure tests showed the NDMA concentration in a patient’s urine to be more than 15,000 times higher than the California drinking water limit. A Stanford study studied NDMA levels in patients 24 before taking ranitidine and 24 hours. They found the NDMA levels in urine increased by 430 times, averaging 47,600 ng per person. That is 495 times higher than the FDA daily limit of NDMA. Scientists have also tested other heartburn medications such as Prilosec, Nexium, Prevacid, and Pepcid. They did not contain levels of NDMA. However, they have been linked to kidney disease, renal failure, and other kidney damage.
Which cancers does Zantac cause?
Zantac may cause the following cancers. This is a non-exhaustive list.
- Bladder Cancer
- Brain Cancer
- Breast Cancer
- Colorectal (Colon) Cancer
- Esophageal Cancer
- Intestinal/Small Intestine Cancer
- Kidney Cancer
- Liver Cancer
- Lung Cancer
- Multiple Myeloma
- Nasal Cancer
- Non-Hodgkin’s Lymphoma (also linked to Roundup Weed Killer)
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Stomach Cancer
- Testicular Cancer
- Throat Cancer
- Thyroid Cancer
- Uterine Cancer
If you are looking for an experienced attorney to handle your or your loved one’s Zantac case, we’d like to partner with you. Contact the product liability attorneys at The Ruth Law Team at 888-783-8378. We have decades of experience going up against big corporations. We fight for our clients’ rights and are here for you. The Ruth Law Team also handles wrongful death claims related to Zantac. Our phone lines are open 24/7, or you may contact us using the web form on this page.